Pan‐pox‐specific T‐cell responses in HIV‐1‐infected individuals after JYNNEOS vaccination
Open Access
- 27 December 2023
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 96 (1) , e29317
Abstract
People living with human immunodeficiency virus (HIV) are the individuals most affected by the current Monkeypox virus outbreak that was first announced in May 2022. Here we report Pan‐pox‐specific T‐cell responses in a cohort of HIV‐1‐infected individuals after receiving the nonreplicative, attenuated smallpox vaccine JYNNEOS from Bavarian Nordic. Intradermal (i.d.) and subcutaneous (s.c.) vaccination was safe without major side effects. Dose‐sparing i.d. vaccination was superior to s.c. vaccination and promoted T‐cell polyfunctionality, and the expression of the gut‐homing marker α4β7 integrin on lymphocytes. HIV‐1‐infected individuals with CD4 T‐cell counts ≤500/mm3 blood required at least a booster vaccination to exhibit efficient virus‐specific T‐cell responses. The magnitude of the Th1 response after this booster directly correlated with the CD4 T‐cell count of the vaccinees. Further studies with a larger number of participants are warranted to confirm and expand our observations.Keywords
This publication has 16 references indexed in Scilit:
- Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose — 32 U.S. Jurisdictions, July 31–September 3, 2022MMWR. Morbidity and Mortality Weekly Report, 2022
- Monkeypox: disease epidemiology, host immunity and clinical interventionsNature Reviews Immunology, 2022
- Anti-SARS-COV-2 specific immunity in HIV immunological non-responders after mRNA-based COVID-19 vaccinationFrontiers in Immunology, 2022
- Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022New England Journal of Medicine, 2022
- The 2022 outbreak and the pathobiology of the monkeypox virusJournal of Autoimmunity, 2022
- Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022MMWR. Morbidity and Mortality Weekly Report, 2022
- Monkeypox goes global: why scientists are on alertNature, 2022
- Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of CongoProceedings of the National Academy of Sciences, 2010
- Dynamic T cell migration program provides resident memory within intestinal epitheliumJournal of Experimental Medicine, 2010
- The immunology of smallpox vaccinesCurrent Opinion in Immunology, 2009